Connection

Robert Malcolm to Middle Aged

Back to Details
This is a "connection" page, showing publications Robert Malcolm has written about Middle Aged.
Robert Malcolm
Connection Strength
0.611
Middle Aged
  1. Physician acceptance of academic detailing for schizophrenia among South Carolina Medicaid providers. J S C Med Assoc. 2012 Aug; 108(4):100-2.
    View in: PubMed
    Score: 0.029
  2. The Obsessive Compulsive Cocaine Scale: assessment of factor structure, reliability, and validity. Addict Behav. 2011 Dec; 36(12):1223-7.
    View in: PubMed
    Score: 0.027
  3. Efficacy of a combination of flumazenil and gabapentin in the treatment of alcohol dependence: relationship to alcohol withdrawal symptoms. J Clin Psychopharmacol. 2009 Aug; 29(4):334-42.
    View in: PubMed
    Score: 0.023
  4. Measures of cognitive functioning as predictors of treatment outcome for cocaine dependence. J Subst Abuse Treat. 2009 Dec; 37(4):328-34.
    View in: PubMed
    Score: 0.023
  5. Is cocaine desire reduced by N-acetylcysteine? Am J Psychiatry. 2007 Jul; 164(7):1115-7.
    View in: PubMed
    Score: 0.020
  6. Self-reported sleep, sleepiness, and repeated alcohol withdrawals: a randomized, double blind, controlled comparison of lorazepam vs gabapentin. J Clin Sleep Med. 2007 Feb 15; 3(1):24-32.
    View in: PubMed
    Score: 0.020
  7. An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: a pilot study. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30; 31(2):389-94.
    View in: PubMed
    Score: 0.019
  8. Risk factors for delirium tremens: a retrospective chart review. Am J Addict. 2006 May-Jun; 15(3):213-9.
    View in: PubMed
    Score: 0.019
  9. A retrospective chart review comparing tiagabine and benzodiazepines for the treatment of alcohol withdrawal. J Psychoactive Drugs. 2005 Dec; 37(4):409-14.
    View in: PubMed
    Score: 0.018
  10. A controlled trial of amlodipine for cocaine dependence: a negative report. J Subst Abuse Treat. 2005 Mar; 28(2):197-204.
    View in: PubMed
    Score: 0.017
  11. Night eating syndrome: effects of brief relaxation training on stress, mood, hunger, and eating patterns. Int J Obes Relat Metab Disord. 2003 Aug; 27(8):970-8.
    View in: PubMed
    Score: 0.015
  12. Amlodipine reduces blood pressure and headache frequency in cocaine-dependent outpatients. J Psychoactive Drugs. 2002 Oct-Dec; 34(4):415-9.
    View in: PubMed
    Score: 0.015
  13. Divalproex loading in the treatment of cocaine dependence. J Psychoactive Drugs. 2001 Jul-Sep; 33(3):283-7.
    View in: PubMed
    Score: 0.013
  14. Gabapentin in the treatment of cocaine dependence: a case series. J Clin Psychiatry. 2001 Jan; 62(1):19-23.
    View in: PubMed
    Score: 0.013
  15. Adverse outcomes in a controlled trial of pergolide for cocaine dependence. J Addict Dis. 2001; 20(1):81-92.
    View in: PubMed
    Score: 0.013
  16. Multiple previous detoxifications are associated with less responsive treatment and heavier drinking during an index outpatient detoxification. Alcohol. 2000 Nov; 22(3):159-64.
    View in: PubMed
    Score: 0.013
  17. A double-blind, placebo-controlled outpatient trial of pergolide for cocaine dependence. Drug Alcohol Depend. 2000 Aug 01; 60(2):161-8.
    View in: PubMed
    Score: 0.013
  18. N-acetylcysteine for the treatment of comorbid alcohol use disorder and posttraumatic stress disorder: Design and methodology of a randomized clinical trial. Contemp Clin Trials. 2020 04; 91:105961.
    View in: PubMed
    Score: 0.012
  19. Divalproex in the treatment of alcohol withdrawal. Am J Drug Alcohol Abuse. 2000 Feb; 26(1):155-60.
    View in: PubMed
    Score: 0.012
  20. Changes in weight control behaviors and hedonic hunger in a commercial weight management program adapted for individuals with type 2 diabetes. Int J Obes (Lond). 2020 05; 44(5):990-998.
    View in: PubMed
    Score: 0.012
  21. Cardiac and mood-related changes during short-term abstinence from crack cocaine: the identification of possible withdrawal phenomena. Am J Drug Alcohol Abuse. 1999 Nov; 25(4):629-37.
    View in: PubMed
    Score: 0.012
  22. Amlodipine treatment of cocaine dependence. J Psychoactive Drugs. 1999 Apr-Jun; 31(2):117-20.
    View in: PubMed
    Score: 0.011
  23. Carbohydrate-deficient transferrin and alcohol use in medical examiner cases. Alcohol. 1999 Jan; 17(1):7-11.
    View in: PubMed
    Score: 0.011
  24. Characteristics of Weight Loss Trajectories in a Comprehensive Lifestyle Intervention. Obesity (Silver Spring). 2017 12; 25(12):2062-2067.
    View in: PubMed
    Score: 0.010
  25. Impact on psychosocial outcomes of a nationally available weight management program tailored for individuals with type 2 diabetes: Results of a randomized controlled trial. J Diabetes Complications. 2017 May; 31(5):891-897.
    View in: PubMed
    Score: 0.010
  26. Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers. Drug Alcohol Depend. 2017 Mar 01; 172:9-13.
    View in: PubMed
    Score: 0.010
  27. A Double-Blind, Randomized, Controlled Pilot Trial of N-Acetylcysteine in Veterans With Posttraumatic Stress Disorder and Substance Use Disorders. J Clin Psychiatry. 2016 Nov; 77(11):e1439-e1446.
    View in: PubMed
    Score: 0.010
  28. Randomized controlled trial of a nationally available weight control program tailored for adults with type 2 diabetes. Obesity (Silver Spring). 2016 11; 24(11):2269-2277.
    View in: PubMed
    Score: 0.010
  29. Effects on cardiovascular risk factors of weight losses limited to 5-10. Transl Behav Med. 2016 09; 6(3):339-46.
    View in: PubMed
    Score: 0.010
  30. Pilot trial of gabapentin for the treatment of benzodiazepine abuse or dependence in methadone maintenance patients. Am J Drug Alcohol Abuse. 2016 05; 42(3):333-40.
    View in: PubMed
    Score: 0.009
  31. Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis. Neuropsychopharmacology. 2016 07; 41(8):1974-82.
    View in: PubMed
    Score: 0.009
  32. Neurocognitive status is associated with all-cause mortality among psychiatric, high-risk liver transplant candidates and recipients. Int J Psychiatry Med. 2015; 49(4):279-95.
    View in: PubMed
    Score: 0.009
  33. Emotional eating, marital status and history of physical abuse predict 2-year weight loss in weight loss surgery patients. Eat Behav. 2014 Dec; 15(4):619-24.
    View in: PubMed
    Score: 0.008
  34. Screening for current opioid misuse and associated risk factors among patients with chronic nonalcoholic pancreatitis pain. Pain Med. 2014 Aug; 15(8):1359-64.
    View in: PubMed
    Score: 0.008
  35. Changes in cardiovascular risk factors with participation in a 12-week weight loss trial using a commercial format. Eat Behav. 2014 Jan; 15(1):68-71.
    View in: PubMed
    Score: 0.008
  36. Relations of hedonic hunger and behavioral change to weight loss among adults in a behavioral weight loss program utilizing meal-replacement products. Behav Modif. 2013 Nov; 37(6):790-805.
    View in: PubMed
    Score: 0.008
  37. A placebo-controlled trial of buspirone in anxious inpatient alcoholics. Alcohol Clin Exp Res. 1992 Dec; 16(6):1007-13.
    View in: PubMed
    Score: 0.007
  38. Chronic pain among liver transplant candidates. Prog Transplant. 2012 Dec; 22(4):379-84.
    View in: PubMed
    Score: 0.007
  39. Pergolide mesylate treatment of cocaine withdrawal. J Clin Psychiatry. 1991 Jan; 52(1):39-40.
    View in: PubMed
    Score: 0.006
  40. Distinctive characteristics of methamphetamine users presenting at public clinics: steep rise in South Carolina, United States, 2000-2005. Drug Alcohol Depend. 2011 May 01; 115(1-2):9-15.
    View in: PubMed
    Score: 0.006
  41. Application of behavioral principles in the management of suffocation phobia: a case study of chronic respiratory failure. Int J Psychiatry Med. 1989; 19(3):281-9.
    View in: PubMed
    Score: 0.006
  42. The role of cystine-glutamate exchange in nicotine dependence in rats and humans. Biol Psychiatry. 2009 May 15; 65(10):841-5.
    View in: PubMed
    Score: 0.006
  43. Differences between adult non-drug users versus alcohol, cocaine and concurrent alcohol and cocaine problem users. Addict Behav. 2009 Mar; 34(3):323-6.
    View in: PubMed
    Score: 0.006
  44. Remission of metabolic syndrome following a 15-week low-calorie lifestyle change program for weight loss. Int J Obes (Lond). 2009 Jan; 33(1):144-50.
    View in: PubMed
    Score: 0.006
  45. Naltrexone and dysphoria: a double-blind placebo controlled trial. Biol Psychiatry. 1987 Jun; 22(6):710-6.
    View in: PubMed
    Score: 0.005
  46. Silver acetate gum as a deterrent to smoking. Chest. 1986 Jul; 90(1):107-11.
    View in: PubMed
    Score: 0.005
  47. Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals. Am J Addict. 2006 Jan-Feb; 15(1):105-10.
    View in: PubMed
    Score: 0.005
  48. A controlled trial of naltrexone in obese humans. Int J Obes. 1985; 9(5):347-53.
    View in: PubMed
    Score: 0.004
  49. Modafinil influences the pharmacokinetics of intravenous cocaine in healthy cocaine-dependent volunteers. Clin Pharmacokinet. 2005; 44(7):753-65.
    View in: PubMed
    Score: 0.004
  50. Insomnia and its treatment. When are hypnotics justified? Postgrad Med. 1984 Jul; 76(1):83-90.
    View in: PubMed
    Score: 0.004
  51. Gabapentin abuse in inmates with prior history of cocaine dependence. Am J Addict. 2004 May-Jun; 13(3):321-3.
    View in: PubMed
    Score: 0.004
  52. Family-focused smoking cessation:enhanced efficacy by the addition of partner support and group therapy. Subst Abus. 2004 Mar; 25(1):37-41.
    View in: PubMed
    Score: 0.004
  53. Carbamazepine in the treatment of cocaine dependence: subtyping by affective disorder. Exp Clin Psychopharmacol. 2002 Aug; 10(3):276-85.
    View in: PubMed
    Score: 0.004
  54. Gabapentin for misuse of homemade nicotine nasal spray. Am J Psychiatry. 2001 Mar; 158(3):498.
    View in: PubMed
    Score: 0.003
  55. Psychosocial aspects of total parenteral nutrition. Psychosomatics. 1980 Feb; 21(2):115-25.
    View in: PubMed
    Score: 0.003
  56. Multiple previous alcohol detoxifications are associated with decreased medial temporal and paralimbic function in the postwithdrawal period. Alcohol Clin Exp Res. 1999 Jun; 23(6):1077-84.
    View in: PubMed
    Score: 0.003
  57. The role of weight control as a motivation for cocaine abuse. Addict Behav. 1998 Mar-Apr; 23(2):201-7.
    View in: PubMed
    Score: 0.003
  58. Pergolide mesylate. Adverse events occurring in the treatment of cocaine dependence. Am J Addict. 1997; 6(2):117-23.
    View in: PubMed
    Score: 0.002
  59. Alcohol treatment: measurement of effectiveness by global outcome. Soc Work Health Care. 1996; 23(3):57-71.
    View in: PubMed
    Score: 0.002
  60. Alcohol detoxification and withdrawal seizures: clinical support for a kindling hypothesis. Biol Psychiatry. 1988 Mar 01; 23(5):507-14.
    View in: PubMed
    Score: 0.001
  61. Naltrexone hydrochloride (Trexan): a review of serum transaminase elevations at high dosage. NIDA Res Monogr. 1986; 67:66-72.
    View in: PubMed
    Score: 0.001
  62. Treatment of insomnia in cancer patients using muscle relaxation training. J Behav Ther Exp Psychiatry. 1983 Sep; 14(3):251-6.
    View in: PubMed
    Score: 0.001
  63. Restraint and age at onset of obesity. Addict Behav. 1981; 6(2):135-8.
    View in: PubMed
    Score: 0.001
  64. Experienced control and participation in treatment of obesity. Psychol Rep. 1980 Dec; 47(3 Pt 2):1127-34.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.